China Regenerative Medicine International Limited Stock
Equities
8158
KYG2129W1380
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.27 HKD | 0.00% | -3.57% | -50.91% |
Sales 2021 | 283M 36.14M | Sales 2022 | 232M 29.59M | Capitalization | 317M 40.47M |
---|---|---|---|---|---|
Net income 2021 | 13M 1.66M | Net income 2022 | 4M 511K | EV / Sales 2021 | 2.92 x |
Net Debt 2021 | 25.9M 3.31M | Net Debt 2022 | 70.16M 8.96M | EV / Sales 2022 | 1.67 x |
P/E ratio 2021 |
59.9
x | P/E ratio 2022 |
69.6
x | Employees | 46 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 37.05% |
1 week | -3.57% | ||
Current month | -6.90% | ||
1 month | -6.90% | ||
3 months | -49.06% | ||
6 months | -50.91% | ||
Current year | -50.91% |
Managers | Title | Age | Since |
---|---|---|---|
Chuang Wang
CEO | Chief Executive Officer | 45 | 19-10-17 |
Po Tin Wong
DFI | Director of Finance/CFO | 47 | 22-08-31 |
Jinnan Zhang
CTO | Chief Tech/Sci/R&D Officer | 39 | 18-09-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Man Fai Leung
BRD | Director/Board Member | 66 | 21-12-29 |
Ho Yin Tsang
BRD | Director/Board Member | 39 | 20-01-29 |
Chuang Wang
CEO | Chief Executive Officer | 45 | 19-10-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.27 | 0.00% | 0 |
24-04-25 | 0.27 | -3.57% | 0 |
24-04-24 | 0.28 | 0.00% | 0 |
24-04-23 | 0.28 | 0.00% | 0 |
24-04-22 | 0.28 | 0.00% | 0 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 04:08 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-50.91% | 10.49M | |
-2.31% | 185B | |
-3.20% | 105B | |
-5.04% | 66.59B | |
+0.20% | 54.66B | |
+17.29% | 47.78B | |
+4.06% | 41.26B | |
+2.36% | 26.95B | |
+2.07% | 26.37B | |
+12.96% | 24.8B |
- Stock Market
- Equities
- 8158 Stock